The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of 
Introduction
Fanconi anemia (FA) is an autosomal recessive cancer susceptibility syndrome characterized by childhood-onset aplastic anemia, multiple congenital anomalies, and cellular sensitivity to DNA crosslinking agents, such as mitomycin C (MMC) and diepoxybutane [1] . FA can be divided into at least eight complementation groups (FA-A, FA-B, FA-C, FA-D1, FA-D2, FA-E, FA-F, and FA-G) [2, 3] . Six FA genes (FANCA, FANCC, FANCD2, FANCE, FANCF, and FANCG) have been cloned [1] . Products of these six FA genes have no homology with other known proteins, and they do not have homology to each other. Because the clinical phenotypes of FA patients for any complementation group are similar, these proteins appear to cooperate in a common pathway.
FANCA, FANCC, FANCF, and FANCG proteins assemble in a multisubunit nuclear complex (FA protein complex) [4] [5] [6] [7] . Formation of the FA protein complex is impaired in FA-A, B, C, E, F, and G cells, but is intact in FA-D1 and FA-D2 cells [5, 8] .
The FA protein complex is required for the monoubiquitination of FANCD2 on Lysine 561, and this monoubiquitination is essential for function of the FA pathway and for MMC resistance [9] . In non-FA cells or in FA -D1 cells, FANCD2 is monoubiquitinated and translocated to nuclear foci containing BRCA1 in response to DNA damage, such as ionizing radiation (IR), ultraviolet light (UV), or MMC treatment. In FA cells, except for the FA-D1 subtype [7] , FANCD2 is not monoubiquitinated and does not form nuclear foci. Thus, the FANCD2 protein is downstream of FA protein complex formation. The product of the FANCD1 gene, which has not yet been cloned, may act further downstream in the pathway or in another pathway. BRCA1 is also required for the efficient monoubiquitination of FANCD2, and BRCA1 deficient cells, like FA cells, are hypersensitive to MMC [9, 10] . Taken together, these findings suggest that the FA pathway is involved in the DNA damage response in the nucleus.
The recently cloned FANCE gene encodes a protein of 536 amino acids, which has no homology to known proteins, but contains two putative nuclear localization signals [11] . The gene has 10 exons and maps to human chromosome 6p21. 2-21.3 [12] . Furthermore, in vitro translated FANCE co-immunoprecipitates with in vitro translated FANCC, suggesting that FANCE is a member of the FA protein complex [12] . However, the characterization of FANCE protein in vivo and its possible role in the FA pathway has not yet been described.
In the current study, we examined the FANCE protein in normal and FA cells.
We found that HA-tagged FANCE protein is localized predominantly in the nucleus and co-immunoprecipitates with FANCA, FANCC, FANCG, but not with FANCD2. , and FA-G (EUFA316)) have been previously described [8, 11, [13] [14] [15] [16] . The SV40-transformed FA fibroblasts, GM0637 (wild type), GM6914 (FA-A), PD426 (FA-C), FAG326SV (FA-G), and PD20F (FA-D2), as well as HeLa cells, were grown in DMEM supplemented with 15% FCS.
Retroviral infection and MMC sensitivity assays
The retroviral expression vector, pMMP-puro, [17] FANCF, [7] , and FANCG [5] have been described previously. Anti-HA antibody (HA.11, Babco) was purchased.
Immunoprecipitation
Whole cell extracts were prepared in Lysis Buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% (v/v) Triton X-100) supplemented with protease inhibitors (1 µg /mL leupeptin and pepstatin, 2 µg /mL aprotinin, 1 mM phenylmethylsulfonylfluoride (PMSF)) and phosphatase inhibitors (1 mM sodium orthovanadate, 10 mM sodium fluoride). Using the polyclonal antibodies to FANCD2 (E35), FANCA, FANCC, and FANCG, immunoprecipitation (IP) was performed essentially as described [4] except that each IP was normalized to contain 2mg of protein. As a negative control, preimmune serum from a rabbit was used.
Immunoblotting
Cells were lysed with 1X sample buffer (50 mM Tris-HCl pH6.8, 86mM 2-mercaptoethanol, 2% sodium dodecyl sulfate (SDS)), boiled for 5 min, and subjected to 7 or 7.5% (10% for FANCF detection) polyacrylamide SDS gel electrophoresis. After electrophoresis, proteins were transferred to nitrocellulose membranes using a submerged transfer apparatus (BioRad) filled with 25 mM Tris base, 200 mM glycine, 20% methanol. After blocking with 5% non-fat dried milk in TBS-T (50mM Tris-HCl, pH 8.0, 150mM NaCl, 0.1% Tween 20), the membrane was incubated with the primary antibody diluted in TBS-T (1:1000 dilution), washed extensively, and incubated with the appropriate horseradish peroxidase-linked secondary antibody (Amersham).
Chemiluminescence was used for detection.
Subcellular fractionation
Cells were fractionated into cytoplasmic and nuclear proteins by hypotonic swelling. Cells were incubated in buffer A (10mM HEPES pH7.9, 10mM KCl, 0.1mM EDTA, 0.1mM EGTA, 1mM PMSF, 1mM DL-Dithiothreitol (DTT)) on ice for 15minutes and NP40 (0.6% final concentration) was added. Nuclei were pelleted by 
Generation of DNA Damage
Gamma irradiation was delivered using a Gammacell 40 apparatus. For mitomycin C (Sigma) treatment, cells were continuously exposed to the drug for the indicated time.
Immunofluorescence Microscopy
Cells were fixed with 2% paraformaldehyde in phosphate buffered saline (PBS) for 20 min., followed by permeabilization with 0.2% Triton-X-100 in PBS (3 min).
Specific antibodies were added at the appropriate dilution in 3% bovine serum albumin/0.05% Triton X-100/0.04% Sodium azide/PBS and incubated for 1 hours at room temperature. FANCD2 was detected using the affinity-purified E35 polyclonal antibody (1/200) . For HA detection, a commercial monoclonal antibody (HA.11, Babco) (1/200) was used. Cells were subsequently washed three times in PBS and speciesspecific fluorescein or Texas red-conjugated secondary antibodies (Jackson Immunoresearch) were diluted in 3% bovine serum albumin/0.05% Triton X-100/0.04% sodium azide/PBS (anti-mouse 1/500, anti-rabbit 1/500) and added. After 30minutes at room temperature three more washes were applied and the nuclei were counterstained with 4', 6-diamidino-2-phenylindole dihydrochloride (DAPI) diluted in PBS at 1 µg/mL for 5 minutes. Three more washes were applied, and the slides were mounted in Vectashield (Vector laboratories). Images were captured on a Nikon microscope and processed using Adobe Photoshop software. 
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Previously we showed that the assembly of FANCD2 nuclear foci correlates with the existence of the monoubiquitinated isoform of FANCD2 (FANCD2-L). Cellular exposure to DNA damaging agents causes an increase of the FANCD2 nuclear foci [9] . Therefore, we examined FANCD2 nuclear foci formation immunocytochemically in FA-E and corrected FA-E cells. Consistently, FA-E cells showed no FANCD2 foci, and correction of FA-E cells with either pMMP-puro FANCE or pMMP-puro HA-FANCE restored the formation of nuclear FANCD2 foci ( Figure 1D ). Thus, reintroduction of (HA-) FANCE cDNA in FA-E cells restored MMC resistance, FANCA/FANCC binding, and monoubiquitination and nuclear foci formation of FANCD2.
Nuclear localization of HA-tagged FANCE protein
We also confirmed the expression of HA-tagged FANCE in the corrected cells immunocytochemically. HA-FANCE was localized mainly in the nuclei of the corrected cells ( Figure 1D ). We also generated HA-FANCE-stably transfected fibroblasts and nuclear foci, as previously described [9] . HA-FANCE was located diffusely in the nucleus; however, no nuclear FANCE foci were observed, even after exposure to these agents ( Figure 2B ).
FANCE interacts with FANCA, FANCC, and FANCG in vivo .

To test if FANCE interacts with other FA proteins, co-immunoprecipitation (IP)
experiments were performed using HeLa cells stably transfected with HA-FANCE. HA- 
FANCE is required for the nuclear accumulation of FANCC.
The expression level of FANCC was low in three independent FA-E cell lines (EUFA130, EUFA410, and EUFA622), and reintroduction of the (HA-) FANCE cDNA into these cell lines caused an increase of the expression levels of FANCC protein ( Figure   1C lanes 4-12, and Figure 4A, lanes 3-8) . Next we examined the effect of FANCE expression on the subcellular localization of FANCC protein. In the absence of FANCE, FANCC protein levels low in both the cytoplasm and nucleus ( Figure 4B , lanes 5, 6, 9, 10, 13, 14) . After reintroduction of HA-FANCE in these FA-E cells, FANCC protein levels increased, especially in the nucleus ( Figure 4B, lanes 8,12, and 16 ). In contrast, FANCC nuclear accumulation was independent of FANCA expression ( Figure 4B , lanes 19-24). Absence of FANCG affected the nuclear accumulation of FANCC to a lesser extent ( Figure 4B lanes 25-30) . Thus, FANCE is required for the nuclear accumulation of the FANCC protein.
Discussion
The six cloned FA proteins interact in a common cellular pathway, regulating the DNA damage response. Activation of FANCD2 to a monoubiquitinated isoform is regulated by the upstream multisubunit nuclear FA protein complex, containing FANCA, FANCC, FANCF and FANCG [6, 9] . FANCE deficient cells lack the ability to monoubiquitinate FANCD2 [9] and direct interaction of FANCE protein and FANCC protein has been shown in vitro [12] . These findings have led to the hypothesis that FANCE is also a component of the nuclear FA protein complex in vivo.
First we generated pMMP retroviral constructs with wild type FANCE cDNA or HA-tagged FANCE cDNA. Both retroviruses corrected FA-E cells with respect to MMC sensitivity, the FANCA/FANCC interaction, FANCD2 monoubiquitination, and nuclear only.
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The reintroduction of (HA-) FANCE in FA-E cells restored FANCA/FANCC interaction ( Figure 1B) . FANCA/FANCC interaction is considered to be indirect and requires FANCA, FANCB, FANCC, FANCE, FANCF, and FANCG, but not FANCD1, or FANCD2 [5, 8] . In contrast, the FANCA/FANCG interaction is direct [5, 12] and does not require other FA proteins. Our current findings are consistent with these previous observations.
The reintroduction of FANCE in FA-E cells restored the monoubiquitination and nuclear foci formation of FANCD2 ( Figures 1C and 1D) . We have previously shown a similar effect for the reintroduction of FANCA, FANCC, FANCF and FANCG cDNAs in FA-A, FA-C, FA-F, and FA-G cells respectively [7, 9] . This finding supports a role of FANCE in the monoubiquitination of FANCD2 through its cooperation with other FA proteins.
We showed that HA-FANCE protein is localized to the nucleus, irrespective of the expression of other FA proteins (Figure 2A) . Consistently, FANCE has two nuclear localization signals [11] . We examined the effect of DNA damage on the subnuclear localization of FANCE, and HA-FANCE was always detected diffusely in the nucleus.
In contrast to FANCD2, we could not detect nuclear foci of HA-FANCE, even after treatment with DNA damaging agents ( Figure 2B) . Absence of FANCE foci may result from overexpression of exogenous HA-FANCE protein.
This study is the first demonstration of the in vivo interaction of FANCE and other components of the FA complex, including FANCA, FANCC, and FANCG ( Figure   3 ). Our findings indicates that FANCE is a component of the FA protein complex. In the yeast two-hybrid system, a strong interaction of FANCE and FANCC was observed.
Also, in vitro translated FANCE and FANCC bind directly and coimmunoprecipitate [12] . Co-immunoprecipitation of in vitro translated FANCE and FANCA or FANCE and FANCG was not observed [12] . The difference between the in vivo results and the in vitro results can be explained by the presence of other factors required for the interaction of FANCE and FANCA (or FANCG) in the cell lysates. We could not detect the only.
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In three independent FA-E cell lines, the expression level of FANCC protein was consistently low. The reintroduction of FANCE into those cell lines caused an increase of the expression level of FANCC protein, especially in the nucleus, suggesting a critical role of the FANCE protein in the accumulation of FANCC in the nucleus (Figure 4 ) [12] .
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